List of insiders holdings for Edgewise Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Thompson Peter A. Director 10% Owner | 2024-01-25 16:32:07 | 0 14,756,096 | 14,756,096 | Form 4 |
| ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner | 2024-01-25 16:28:46 | 0 14,756,096 | 14,756,096 | Form 4 |
| Novo Holdings A/S 10% Owner | 2024-01-25 16:26:29 | 6,344,430 0 | 6,344,430 | Form 13D |
| Flynn James E Deerfield Mgmt IV L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund IV L.P. Possible Member of 10% Group 10% Owner | 2024-02-01 17:28:19 | 4,478,592 0 | 4,478,592 | Form 13G |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 2021-03-30 17:12:14 | 681,812 0 | 681,812 | Form 4 |
| KOCH KEVIN President and CEO | 2024-05-03 18:26:53 | 24,895 338,784 | 363,679 | Form 4 |
| Semigran Marc Chief Development Officer | 2023-08-18 19:13:10 | 133,333 0 | 133,333 | Form 4 |
| Carruthers R Michael Chief Financial Officer | 2024-05-03 18:30:08 | 40,439 0 | 40,439 | Form 4 |
| Morris Arlene Director | 2024-05-07 19:52:00 | 34,311 0 | 34,311 | Form 4 |
| Donovan Joanne M. CMO | 2024-05-03 18:27:48 | 30,314 0 | 30,314 | Form 4 |
| Edris Badreddin Director | 2023-06-14 19:29:21 | 22,123 0 | 22,123 | Form 4 |
| ROOT JONATHAN D Director | 2023-06-14 19:29:32 | 22,123 0 | 22,123 | Form 4 |
| Brege Laura Director | 2023-06-14 19:29:09 | 22,123 0 | 22,123 | Form 4 |
| Derakhshan Behrad Chief Business Officer | 2024-05-03 18:29:16 | 18,631 0 | 18,631 | Form 4 |
| Russell Alan J Chief Scientific Officer | 2024-05-03 18:28:24 | 12,447 0 | 12,447 | Form 4 |
| Fox Jonathan C Director | 2023-12-28 16:39:30 | 10,857 0 | 10,857 | Form 4 |
| MOORE JOHN R General Counsel | 2024-05-03 18:31:04 | 8461 0 | 8461 | Form 4 |
| Harrison Kenneth Ph.D. Director | 2021-03-25 21:37:16 | 0 0 | 0 | Form 3 |